Your Portfolio
Enrollment time reduction
Predictive EHR scoring + multi-site coordination benchmarks suggest 30–40% reduction in time-to-full-enrollment for AI-assisted trials. We use 35% as the midpoint.
- Source: Tufts Center for the Study of Drug Development (CSDD) — AI-augmented recruitment lifting site activation and screening velocity
- Source: BIO Clinical Development Success Rates
Screen-fail savings formula
Delay cost avoidance formula
Default $40,000/site/month is Phase II benchmark from Tufts CSDD (includes site staff, IRB fees, monitoring, and opportunity cost). Phase III typically runs $80K–$120K/site/month.
Syncra pricing
Net ROI & ROI multiple
ROI multiple is gross value divided by cost — how many dollars returned per dollar spent. Net ROI is the dollar surplus.
What this doesn't include
- Staff time savings (coordinator hours freed from manual chart review — typically 15–20 hrs/week/site)
- Improved data quality and reduced protocol deviations from AI-assisted screening
- Patient retention improvements (Syncra agents maintain engagement post-screen)
- Cross-trial learnings compounding over time
All estimates are conservative. Real-world deployments typically show higher returns once staff reallocation is included.
These numbers real for your portfolio?
Book a 20-minute walkthrough. We'll verify the math against your actual trial data and show you the live dashboard.
Talk to the team →